Logo

IVP

Inspire Veterinary Partners, Inc.

IVP

Inspire Veterinary Partners, Inc. • NASDAQ
$0.12 ▼ -9.42% (-0.01)
Market Cap $313263
52w High $6.30
52w Low $0.10
Dividend Yield 0%
P/E 0
Volume 7.31M
Outstanding Shares 2.52M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $4.316M ▲ $3.604M ▼ $-2.526M ▲ -58.531% ▲ $-0.415 ▲ $-1.637M ▲
Q2-2025 $4.284M ▲ $4.464M ▲ $-3.035M ▼ -70.843% ▼ $-0.503 ▼ $-2.31M ▼
Q1-2025 $3.639M ▲ $2.722M ▲ $-2.415M ▲ -66.362% ▲ $-0.435 ▲ $-1.654M ▲
Q4-2024 $3.321M ▼ $2.07M ▼ $-3.967M ▼ -119.439% ▼ $-3.059 ▲ $-2.758M ▼
Q3-2024 $4.049M $2.861M $-3.489M -86.177% $-9.617 $-1.893M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $341.746K ▲ $23.956M ▲ $19.787M ▼ $4.169M ▲
Q2-2025 $158.942K ▼ $20.811M ▲ $20.364M ▲ $446.262K ▼
Q1-2025 $1.738M ▲ $20.661M ▲ $17.657M ▼ $3.004M ▲
Q4-2024 $523.69K ▼ $20.196M ▼ $18.634M ▼ $1.562M ▼
Q3-2024 $681.199K $22.396M $19.366M $3.03M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-2.526M ▲ $-1.283M ▼ $-43.461K ▲ $1.509M ▲ $182.804K ▲ $-1.326M ▼
Q2-2025 $-3.035M ▼ $-898.284K ▲ $-1.863M ▼ $1.296M ▼ $-1.465M ▼ $-910.863K ▲
Q1-2025 $-2.415M ▲ $-1.374M ▼ $-20.275K ▲ $2.529M ▲ $1.134M ▲ $-1.395M ▼
Q4-2024 $-3.967M ▼ $-677.527K ▲ $-31.828K ▼ $551.846K ▼ $-157.509K ▼ $-709.355K ▲
Q3-2024 $-3.489M $-6.309M $-25.519K $7.008M $673.541K $-6.335M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Product
Product
 $0 ▲$0 ▲$0 ▲$0 ▲
Service
Service
 $10.00M ▲$0 ▼$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement The business is still at a very early revenue stage. Sales are small and have only inched up from almost nothing, while operating costs are clearly higher than what the company brings in. That means the company is running at a loss and has not yet shown that its model can scale to cover overhead. Losses have been fairly persistent over the past few years, so financial performance so far looks more like a development‑stage platform than a mature operator of veterinary clinics.

Balance Sheet

Balance Sheet The balance sheet is very thin. The company has only a modest base of assets, largely funded by debt rather than by a solid equity cushion. Shareholders’ equity has hovered around break‑even or slightly negative territory, which suggests limited financial buffer if operations underperform. This structure can make the company more sensitive to setbacks, financing conditions, and any delays in achieving profitable growth.

Cash Flow

Cash Flow Cash flow from day‑to‑day operations is negative, which means the company is still consuming cash rather than generating it. Free cash flow is also negative, though there is little in the way of heavy investment spending so far. That combination points to a lean, capital‑light model but also underlines reliance on outside funding or new capital raises to support the business while it works toward scale and potential profitability.

Competitive Edge

Competitive Edge Inspire Veterinary Partners is trying to stand out in a crowded veterinary market through culture, structure, and technology rather than sheer size. Its employee‑ownership model and people‑first approach are designed to attract and retain veterinarians in an industry with high burnout, which could be a meaningful advantage if it resonates with staff. The AI‑enabled clinic operations and standardized software platform may also support better efficiency and consistency across locations. However, the company is still very small compared with larger veterinary consolidators and established local clinics, so its competitive strength will depend heavily on how well it executes acquisitions, integrates practices, and maintains its culture as it grows.

Innovation and R&D

Innovation and R&D Innovation is a clear focus, with more emphasis on process and business-model innovation than on traditional lab R&D. The partnership with Covetrus to deploy AI tools in clinics aims to automate documentation and administrative work, freeing veterinarians to spend more time with patients. Standardizing on a single practice management system should help with data, KPIs, and operational control. Looking ahead, the planned online pet pharmacy is a notable strategic step that could extend the business beyond physical clinics into digital pet health and eCommerce. The company also signals an openness to more partnerships in pet technology, which could keep it at the forefront of operational innovation if executed well.

Summary

Overall, Inspire Veterinary Partners looks like an early‑stage, concept‑driven platform in veterinary care: financially small, loss‑making, and thinly capitalized, but with a distinctive people‑centric and technology‑enabled strategy. The key strengths lie in its employee‑ownership model, AI‑supported workflows, and ambitions to broaden into online pet pharmacy and other pet‑tech areas. The main risks are its limited financial cushion, ongoing operating losses, and the challenge of competing against much larger, better‑funded veterinary groups while still proving out its model at scale. Future results will depend on the company’s ability to grow its clinic footprint, integrate acquisitions smoothly, turn innovation into consistent profitability, and manage its capital needs along the way.

NEWS

November 12, 2025 · 4:05 PM UTC

Inspire Veterinary Partners Announces Third Quarter 2025 Financial Results

Read more

October 22, 2025 · 8:15 AM UTC

Inspire Veterinary Partners Announces Online Pet Pharmacy

Read more

September 25, 2025 · 8:45 AM UTC

Inspire Veterinary Partners Provides Shareholder Update

Read more

September 2, 2025 · 4:15 PM UTC

Inspire Veterinary Partners to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Read more

September 2, 2025 · 8:15 AM UTC

Inspire Veterinary Partners Regains Compliance with Nasdaq Listing Requirements

Read more